CBNY reports six months net loss of $2.07 million

February 10, 2020


For the six months ended November 30, 2019, Ciboney Group Limited’s (CBNY) financial Income decreased by 57% to total $13,000 from $30,000 in November 30, 2018. For the quarter, financial income closed at $4,000 (2018: $14,000).

Group Operating Expenses totalled $2.08 million for the period relative to $2.26 million for the corresponding period in 2018, an 8% decline. While, for the quarter, group operating expenses amounted to $996,000 (2018: $1.14 million).

The company reported net loss before taxation of $2.07 million, this compares with the loss of $2.23 million in 2018.

No taxes were incurred during the period under review (2018: $120,000) as such, the company booked net loss for the period of $2.07 million (2018:$2.35 million). For the quarter, net loss amounted to $992,000 (2018: $1.19 million).

Loss per share was 0.38 cents for the period (2018: LPS of 0.41 cents). While, for the quarter, loss per share amounted to $0.18 cents (2018: LPS of 0.21 cents). The trailing twelve months loss per a share is $0.0088. The number of shares used in the calculations is 546,000,000.  CBNY stock price closed the trading period at a price of $0.10 on February 10, 2020.


Balance Sheet at a glance:

Total Assets as at November 30, 2019 amounted to $18.51 million, up from $16.08 million as at November 30, 2018. The main reason for the increase in total asset was ‘Cash and Cash Equivalents’ moving up by 25% to close at $12.80 million compared to the $10.27 million reported in 2018.

Shareholders’ Equity amounted to $6.96 million, a decrease relative to shareholders’ equity of $11.77 million reported in 2018. As such, the shareholder’s equity per share stood at 1.28 cents as at November 30, 2019 (2018: 2.16 cents).



Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer(s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view(s) expressed by that research analyst in this research report.

Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.